John G. Harter

1.7k total citations
29 papers, 1.3k citations indexed

About

John G. Harter is a scholar working on Pharmacology, Immunology and Allergy and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John G. Harter has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Immunology and Allergy and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John G. Harter's work include Allergic Rhinitis and Sensitization (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmaceutical studies and practices (5 papers). John G. Harter is often cited by papers focused on Allergic Rhinitis and Sensitization (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmaceutical studies and practices (5 papers). John G. Harter collaborates with scholars based in United States, Canada and Switzerland. John G. Harter's co-authors include William J. Reddy, George W. Thorn, Kamal G. Ishak, Hyman J. Zimmerman, Albert H. Coons, Alpha Banks, Yoshihiro Hamashima, Carl C. Peck, Leonard W. Pollard and Hugh O. McDevitt and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Experimental Medicine.

In The Last Decade

John G. Harter

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John G. Harter United States 16 302 214 152 151 147 29 1.3k
D. Brockmeier Germany 15 261 0.9× 325 1.5× 181 1.2× 148 1.0× 60 0.4× 44 1.2k
L.F. Lacey United Kingdom 19 99 0.3× 223 1.0× 164 1.1× 127 0.8× 286 1.9× 36 1.5k
Vijay Batra United States 17 145 0.5× 216 1.0× 204 1.3× 222 1.5× 67 0.5× 45 1.3k
Bo Odlind Sweden 21 148 0.5× 287 1.3× 178 1.2× 164 1.1× 138 0.9× 56 1.4k
Juan J.L. Lertora United States 24 210 0.7× 285 1.3× 185 1.2× 126 0.8× 93 0.6× 49 1.7k
Eric Snoeck Belgium 18 137 0.5× 176 0.8× 114 0.8× 103 0.7× 73 0.5× 44 1.1k
G Lévy United States 22 297 1.0× 288 1.3× 197 1.3× 139 0.9× 82 0.6× 60 1.4k
Shinichi Kobayashi Japan 19 445 1.5× 223 1.0× 307 2.0× 101 0.7× 132 0.9× 122 1.4k
Diane K. Jorkasky United States 27 204 0.7× 341 1.6× 139 0.9× 144 1.0× 138 0.9× 68 1.7k
Richard E. Mullins United States 20 156 0.5× 645 3.0× 212 1.4× 145 1.0× 331 2.3× 50 2.2k

Countries citing papers authored by John G. Harter

Since Specialization
Citations

This map shows the geographic impact of John G. Harter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Harter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Harter more than expected).

Fields of papers citing papers by John G. Harter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Harter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Harter. The network helps show where John G. Harter may publish in the future.

Co-authorship network of co-authors of John G. Harter

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Harter. A scholar is included among the top collaborators of John G. Harter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Harter. John G. Harter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banks, Alpha, Hyman J. Zimmerman, Kamal G. Ishak, & John G. Harter. (1995). Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology. 22(3). 820–827. 198 indexed citations
2.
Hale, Victoria, et al.. (1994). Sulindac Exploratory modeling and bioequivalence implications. Clinical Pharmacology & Therapeutics. 55(2). 140. 3 indexed citations
3.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1994). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. The Journal of Clinical Pharmacology. 34(2). 111–119. 37 indexed citations
4.
Harter, John G., et al.. (1993). Sulindac-associated hepatic injury: Analysis of 91 cases reported to the food and drug administration. Gastroenterology. 104(2). 569–574. 62 indexed citations
5.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations
6.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clinical Pharmacology & Therapeutics. 51(4). 465–473. 141 indexed citations
7.
Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Pharmaceutical Research. 9(6). 826–833. 41 indexed citations
8.
Harter, John G. & Carl C. Peck. (1991). Chronobiologya. Annals of the New York Academy of Sciences. 618(1). 563–571. 37 indexed citations
9.
Harter, John G.. (1988). Acute Flank Pain and Hematuria: Lessons from Adverse Drug Reaction Reporting. The Journal of Clinical Pharmacology. 28(6). 560–565. 6 indexed citations
10.
Harter, John G.. (1983). THE STATUS OF DIMETHYL SULFOXIDE FROM THE PERSPECTIVE OF THE FOOD AND DRUG ADMINISTRATION. Annals of the New York Academy of Sciences. 411(1). 1–5. 34 indexed citations
11.
Harter, John G.. (1975). Comments from the food and drug administration. The American Journal of Medicine. 58(4). 477–478. 4 indexed citations
12.
Harter, John G., et al.. (1975). Comparison of Antibiotic Therapy in Presumptive Bacterial Conjunctivitis. American Journal of Ophthalmology. 79(5). 790–794. 19 indexed citations
13.
Harter, John G.. (1968). Serum uric acid levels in patients with bronchial asthma. Journal of Allergy. 42(2). 88–92. 3 indexed citations
14.
Harter, John G., et al.. (1967). An evaluation of Gay's solution in the treatment of asthma. Journal of Allergy. 40(6). 327–336. 4 indexed citations
15.
Harter, John G.. (1965). Antihistaminics: Tailoring dosage to suit patients. Clinical Pharmacology & Therapeutics. 6(4). 553–554. 1 indexed citations
16.
Harter, John G., William J. Reddy, & George W. Thorn. (1963). Studies on an Intermittent Corticosteroid Dosage Regimen. New England Journal of Medicine. 269(12). 591–596. 265 indexed citations
17.
Richter, M., John G. Harter, A.H. Sehon, & B. Rose. (1957). Studies on Ragweed Pollen. The Journal of Immunology. 79(1). 13–23. 11 indexed citations
18.
Richter, M., John G. Harter, A.H. Sehon, & B. Rose. (1957). Studies on ragweed pollen. III. Estimation of the minimum number of allergens in the water soluble extract of ragweed pollen and a critical evaluation of the neutralization technique; the demonstration of two different reagins in sera of ragweed sensitive individuals.. PubMed. 79(1). 13–23. 22 indexed citations
19.
Sehon, A.H., et al.. (1956). THE LOCALIZATION OF SKIN-SENSITIZING ANTIBODY IN THE SERA OF RAGWEED-SENSITIVE INDIVIDUALS BY ELECTROPHORESIS. The Journal of Experimental Medicine. 103(5). 679–699. 27 indexed citations
20.
Sehon, A.H., M. Richter, John G. Harter, & B. Rose. (1956). Studies on ragweed pollen. I. Preliminary fractionation of ragweed pollen. Journal of Allergy. 27(3). 236–255. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Brockmeier Breakdown of academic impact, for papers by L.F. Lacey Breakdown of academic impact, for papers by Vijay Batra Breakdown of academic impact, for papers by Bo Odlind Breakdown of academic impact, for papers by Juan J.L. Lertora Breakdown of academic impact, for papers by Eric Snoeck Breakdown of academic impact, for papers by G Lévy Breakdown of academic impact, for papers by Shinichi Kobayashi Breakdown of academic impact, for papers by Diane K. Jorkasky Breakdown of academic impact, for papers by Richard E. Mullins
Rankless by CCL
2026